FirstHealth of the Carolinas

Clinical Trial Details

Study Title: CoMMpass: A Prospective, Longitudinal, Observational Study in Newly Diagnosed Multiple Myeloma (MM) Patients to Assess the Relationship Between Patient Outcomes, Treatment Regimens and Molecular Profiles
Study Type: Observation
Study Condition: Multiple Myeloma
Investigator: Dr. Charles Kuzma
Phone: (910) 715-3500
Research Coordinator: Lori DeSpain
Phone: (910) 715-2200
Eligibility Criteria: Men or women who are newly diagnosed with symptomatic, multiple myeloma. For additional criteria, call the Research Coordinator or visit the study weblink.
Sponsor Organization: Multiple Myeloma Research Foundation
Study Rationale:
Study Purpose: The primary objective of this observational study is to identify the molecular profiles and clinical characteristics that define subsets of myeloma patients during the course of the disease.
Study Link: http://clinicaltrials.gov/show/NCT01454297
   
 
FirstHealth @ Facebook.comFirstHealth @ Twitter.comFirstHealth @ Pinterest.comFirstHealth @ LinkedIn.com
Physicians Employees
Working Together, First in Quality, First in Health
Site MapPrivacy PolicyTerms & ConditionsHelp © FirstHealth of the Carolinas, Inc.